ASH Roundup: Bristol-Myers Squibb, bluebird bio, Oryzon and More Acute Myeloid Leukemia (AML), American Society of Hematology (ASH) Annual Meeting, Chronic Lymphocytic Leukemia (CLL), Clinical Data, Clinical Trials, Diffuse Large B-Cell Lymphoma (DLBCL), Epigenetic, LSD1, Myelodysplastic Syndromes, Progression-Free Survival (PFS), R&D, Relapse/Refractory Multiple Myeloma, Small Lymphocytic Lymphoma (SLL), Small Molecules Hundreds of studies and results were presented at the 61st American Society of Hematology (ASH) Annual Meeting. Read more December 10, 2019/by BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2019-12-10 13:00:532019-12-10 13:00:53ASH Roundup: Bristol-Myers Squibb, bluebird bio, Oryzon and More
